Literature DB >> 12007579

Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery.

O Pauvert1, D Salvail, E Rousseau, C Lugnier, R Marthan, J P Savineau.   

Abstract

Cyclic nucleotides are involved in the control of pulmonary vascular tone. In the present study, we measured the cyclic nucleotide specific phosphodiesterase (PDE) activity in the media of bovine isolated main pulmonary artery (MPA). Total cAMP- and cGMP-PDE activities were measured in microsomal and cytosolic fractions. Both cyclic nucleotides were hydrolysed in these subcellular fractions at consistently higher rate in the cytosolic than in the microsomal fraction. Using different classes of PDE modulator, at least four PDE isoforms (PDE1, 3, 4 and 5) were identified in these fractions. PDE3 (cilostamide-sensitive), PDE4 (rolipram-sensitive) and PDE5 (zaprinast- and DMPPO-sensitive) isoforms appeared as the main isozymes implicated in the cAMP and cGMP hydrolytic activities. Calcium-camodulin stimulated PDE activity (PDE1) was mainly present in the cytosolic fraction. PDE2, although present, had a lower hydrolytic activity since addition of its specific inhibitor, erythro-9-(2-hydroxy-3nonyl)adenine (EHNA), to a combination of inhibitors of PDE3, 4 and 5 produced no further significant reduction in the enzymatic activity. Resolution of PDE activities from the cytosolic fraction using anion exchange chromatography confirmed this finding. Functional experiments performed in endothelium-denuded rings of rat MPA revealed that all specific PDE inhibitors used relaxed precontracted vascular smooth muscle preparations in a concentration-dependent manner. The rank order of potency was cilostamide >zaprinast>rolipram>>EHNA. The present study demonstrates the presence in the smooth muscle cells-containing layer of MPA of PDE1, 3, 4 and 5 isoforms and suggests that PDE3, 4 and 5 are the main enzymes involved in the control of vascular tone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007579     DOI: 10.1016/s0006-2952(02)00919-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

2.  Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.

Authors:  C J Busch; A R Graveline; K Jiramongkolchai; H Liu; L S Sanchez; K D Bloch
Journal:  J Physiol Pharmacol       Date:  2010-12       Impact factor: 3.011

Review 3.  Therapeutic approaches using nitric oxide in infants and children.

Authors:  Robin H Steinhorn
Journal:  Free Radic Biol Med       Date:  2011-01-13       Impact factor: 7.376

4.  Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells.

Authors:  Kathryn N Farrow; Beezly S Groh; Paul T Schumacker; Satyan Lakshminrusimha; Lyubov Czech; Sylvia F Gugino; James A Russell; Robin H Steinhorn
Journal:  Circ Res       Date:  2007-11-08       Impact factor: 17.367

5.  Acute hypoxia modifies cAMP levels induced by inhibitors of phosphodiesterase-4 in rat carotid bodies, carotid arteries and superior cervical ganglia.

Authors:  Ana R Nunes; Joana R Batuca; Emília C Monteiro
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

6.  Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep.

Authors:  Bernadette Chen; Satyan Lakshminrusimha; Lyubov Czech; Beezly S Groh; Sylvia F Gugino; James A Russell; Kathryn N Farrow; Robin H Steinhorn
Journal:  Pediatr Res       Date:  2009-12       Impact factor: 3.756

7.  Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.

Authors:  O Pauvert; C Lugnier; T Keravis; R Marthan; E Rousseau; J P Savineau
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

8.  Acetylcholine and tachykinins involvement in the caffeine-induced biphasic change in intracellular Ca2+ in bovine airway smooth muscle.

Authors:  Luis M Montaño; Verónica Carbajal; José L Arreola; Carlos Barajas-López; Edgar Flores-Soto; Mario H Vargas
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 9.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Authors:  Emily J Tsai; David A Kass
Journal:  Pharmacol Ther       Date:  2009-03-21       Impact factor: 12.310

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.